Myth Busted: ISCAS Isn’t Expensive
Many believe Stage 3 adjudication via ISCAS is prohibitively expensive – but the facts speak for themselves. ISCAS, owned by charity CEDR, is a not-for-profit adjudicator dedicated solely to private healthcare, making it the most experienced, transparent choice in the market. According to ISCAS’s latest data (2024–2025), the average adjudication cost was £1,590, with goodwill … Continue reading Myth Busted: ISCAS Isn’t Expensive
